Literature DB >> 3596885

Pityriasis rosea in Lagos.

Y Olumide.   

Abstract

A recent 5-year period study of the incidence of pityriasis rosea among dermatologic outpatients was conducted at the Lagos University Teaching Hospital. Three hundred fifty-two patients with pityriasis rosea were seen. The average annual incidence was 4.8 per 100 dermatologic patients. Women predominated by a margin of 1.2:1.0. More than 91% of the patients were between the ages of 5 and 35 years, with a peak at ages 10-14. The incidence of the disease was significantly higher in the early part of the rainy season. No declining incidence was observed over the years. A blood picture of a leukopenia with relative lymphocytosis was observed early in the disease. Ampicillin, when consumed after the onset of the eruption, made the patient with pityriasis rosea clinically worse.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3596885     DOI: 10.1111/j.1365-4362.1987.tb00907.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  8 in total

1.  Interventions for pityriasis rosea.

Authors:  Jose Contreras-Ruiz; Sandra Peternel; Carlos Jiménez Gutiérrez; Ivana Culav-Koscak; Ludovic Reveiz; Maria de Lourdes Silbermann-Reynoso
Journal:  Cochrane Database Syst Rev       Date:  2019-10-30

2.  The comparison between the efficacy of high dose acyclovir and erythromycin on the period and signs of pitiriasis rosea.

Authors:  Amirhooshang Ehsani; Nafiseh Esmaily; Pedram Noormohammadpour; Siavash Toosi; Alireza Hosseinpour; Mahbobeh Hosseini; Shima Sayanjali
Journal:  Indian J Dermatol       Date:  2010 Jul-Sep       Impact factor: 1.494

3.  A Randomized, Double-blind, Placebo-Controlled Study of Efficacy of Oral Acyclovir in the Treatment of Pityriasis Rosea.

Authors:  Satyaki Ganguly
Journal:  J Clin Diagn Res       Date:  2014-05-15

4.  An epidemiological study of pityriasis rosea in the Eastern Anatolia.

Authors:  M Harman; S Aytekin; S Akdeniz; H S Inalöz
Journal:  Eur J Epidemiol       Date:  1998-07       Impact factor: 8.082

5.  Acyclovir in pityriasis rosea: An observer-blind, randomized controlled trial of effectiveness, safety and tolerability.

Authors:  Anupam Das; Amrita Sil; Nilay Kanti Das; Kunal Roy; Amal Kanti Das; Debabrata Bandyopadhyay
Journal:  Indian Dermatol Online J       Date:  2015 May-Jun

Review 6.  Pityriasis Rosea, Gianotti-Crosti Syndrome, Asymmetric Periflexural Exanthem, Papular-Purpuric Gloves and Socks Syndrome, Eruptive Pseudoangiomatosis, and Eruptive Hypomelanosis: Do Their Epidemiological Data Substantiate Infectious Etiologies?

Authors:  Antonio Chuh; Vijay Zawar; Gabriel F Sciallis; Werner Kempf; Albert Lee
Journal:  Infect Dis Rep       Date:  2016-03-21

Review 7.  Clinical variants of pityriasis rosea.

Authors:  Francisco Urbina; Anupam Das; Emilio Sudy
Journal:  World J Clin Cases       Date:  2017-06-16       Impact factor: 1.337

Review 8.  Gianotti-Crosti syndrome, pityriasis rosea, asymmetrical periflexural exanthem, unilateral mediothoracic exanthem, eruptive pseudoangiomatosis, and papular-purpuric gloves and socks syndrome: a brief review and arguments for diagnostic criteria.

Authors:  Antonio Chuh; Vijay Zawar; Michelle Law; Gabriel Sciallis
Journal:  Infect Dis Rep       Date:  2012-02-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.